Intensified Adjuvant Cyclophosphamide, Methotrexate and 5-Fluorouracil Therapy: A Dose-Finding Study for Ambulatory Patients with Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|56|2|103-109

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.2, 1999-02, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 330-337

Karger

Access to resources Recommend Favorite

A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 207-213

Karger

Access to resources Recommend Favorite

Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 274-281

Karger

Access to resources Recommend Favorite

Sequential Administration of Doxorubicin and Paclitaxel Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil Combination (CMF) in Women with Metastatic Breast Cancer

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 533-537

Karger

Access to resources Recommend Favorite

Phase I/II Study of Paclitaxel and 5-Fluorouracil as Second-Line Therapy in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 305-308

Karger

Access to resources Recommend Favorite